Company research
Moderna, Inc.
CIK 1682852Updated Sep 24, 2026
SecurityMRNA · NASDAQ · equity
Name history
Moderna Therapeutics, Inc. · through Aug 24, 2016
MRNA price & chart
Loading TradingView…
NASDAQ:MRNA on TradingView ↗In the news
Biologics Market Momentum Accelerates Across Healthcare, AI, And Global Medical Tourism ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 12,338,000,000Source | 14,142,000,000Source | 18,426,000,000Source | 25,858,000,000Source |
| GoodwillUSD | 52,000,000Source | 52,000,000Source | 52,000,000Source | — |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 2,595,000,000Source | 1,927,000,000Source | 2,907,000,000Source | 3,205,000,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 184,000,000Source | 358,000,000Source | 892,000,000Source | 1,385,000,000Source |
| Inventory, NetUSD | 153,000,000Source | 117,000,000Source | 202,000,000Source | 949,000,000Source |
| Assets, CurrentUSD | 6,544,000,000Source | 8,099,000,000Source | 10,325,000,000Source | 13,431,000,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 408,000,000Source | 599,000,000Source | 627,000,000Source | 1,195,000,000Source |
| Operating Lease, Right-of-Use AssetUSD | 719,000,000Source | 759,000,000Source | 713,000,000Source | 121,000,000Source |
| Other Assets, NoncurrentUSD | 605,000,000Source | 594,000,000Source | 685,000,000Source | 988,000,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 3,688,000,000Source | 3,241,000,000Source | 4,572,000,000Source | 6,735,000,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Additional Paid in CapitalUSD | 1,382,000,000Source | 866,000,000Source | 371,000,000Source | 1,173,000,000Source |
| Retained Earnings (Accumulated Deficit)USD | 7,223,000,000Source | 10,045,000,000Source | 13,606,000,000Source | 18,320,000,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 45,000,000Source | -10,000,000Source | -123,000,000Source | -370,000,000Source |
| Stockholders' Equity Attributable to ParentUSD | 8,650,000,000Source | 10,901,000,000Source | 13,854,000,000Source | 19,123,000,000Source |
| Liabilities and EquityUSD | 12,338,000,000Source | 14,142,000,000Source | 18,426,000,000Source | 25,858,000,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 1,987,000,000Source | 2,206,000,000Source | 3,015,000,000Source | 4,923,000,000Source |
| Operating Lease, Liability, CurrentUSD | 17,000,000Source | 14,000,000Source | 25,000,000Source | 35,000,000Source |
| Accounts Payable, CurrentUSD | 317,000,000Source | 405,000,000Source | 520,000,000Source | 487,000,000Source |
| Operating Lease, Liability, NoncurrentUSD | 653,000,000Source | 671,000,000Source | 643,000,000Source | 92,000,000Source |
| Deferred Income Tax Liabilities, NetUSD | 249,000,000Source | 231,000,000Source | — | — |
| Other Liabilities, NoncurrentUSD | 285,000,000Source | 267,000,000Source | 256,000,000Source | 135,000,000Source |
| Additional Financial Items | ||||
| Accounts Receivable, after Allowance for Credit LossUSD | 184,000,000Source | 358,000,000Source | 892,000,000Source | — |
| Accrued Liabilities, CurrentUSD | 1,386,000,000Source | 1,427,000,000Source | 1,798,000,000Source | 2,101,000,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 590,000,000Source | — | — | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 211,000,000Source | 185,000,000Source | 617,000,000Source | 348,000,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 483,000,000Source | 429,000,000Source | 305,000,000Source | 226,000,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -156,000,000Source | -534,000,000Source | -493,000,000Source | -1,790,000,000Source |
| Increase (Decrease) in InventoriesUSD | 34,000,000Source | -83,000,000Source | -747,000,000Source | -492,000,000Source |
| Increase (Decrease) in Accounts PayableUSD | -92,000,000Source | -69,000,000Source | 13,000,000Source | 240,000,000Source |
| Deferred Income Tax Expense (Benefit)USD | 10,000,000Source | -1,000,000Source | 901,000,000Source | -578,000,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -1,873,000,000Source | -3,004,000,000Source | -3,118,000,000Source | 4,981,000,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | 0Source | 0Source | 85,000,000Source | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 1,946,000,000Source | 1,949,000,000Source | 4,206,000,000Source | -5,176,000,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 192,000,000Source | 1,051,000,000Source | 707,000,000Source | 400,000,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | 2,000,000Source | 0Source | 1,153,000,000Source | 3,329,000,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 593,000,000Source | 56,000,000Source | -1,377,000,000Source | -3,448,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 668,000,000Source | -999,000,000Source | -289,000,000Source | -3,643,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 2,597,000,000Source | 1,929,000,000Source | 2,928,000,000Source | 3,217,000,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 10,000,000Source | 24,000,000Source | 39,000,000Source | 25,000,000Source |
| Income Taxes Paid, NetUSD | 26,000,000Source | 197,000,000Source | -357,000,000Source | 2,729,000,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 483,000,000Source | 429,000,000Source | 305,000,000Source | 226,000,000Source |
| Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously RecordedUSD | 0Source | 0Source | 0Source | 0Source |
| Equity Securities, FV-NI, Realized Gain (Loss)USD | -8,000,000Source | -52,000,000Source | -35,000,000Source | — |
| General and Administrative ExpenseUSD | 1,018,000,000Source | 1,174,000,000Source | 1,549,000,000Source | 1,132,000,000Source |
| GoodwillUSD | 52,000,000Source | 52,000,000Source | 52,000,000Source | — |
| Income (Loss) from Equity Method Investments, Net of Dividends or DistributionsUSD | -8,000,000Source | -52,000,000Source | -35,000,000Source | — |
| Income Tax Expense (Benefit)USD | 54,000,000Source | -46,000,000Source | 772,000,000Source | 1,213,000,000Source |
| Inventory Write-downUSD | 291,000,000Source | 495,000,000Source | 2,200,000,000Source | 1,300,000,000Source |
| Investment Income, InterestUSD | 314,000,000Source | 425,000,000Source | 421,000,000Source | 200,000,000Source |
| Net Income (Loss) Attributable to ParentUSD | -2,822,000,000Source | -3,561,000,000Source | -4,714,000,000Source | 8,362,000,000Source |
| Other Depreciation and AmortizationUSD | 215,000,000Source | 189,000,000Source | 621,000,000Source | — |
| Other Nonoperating Income (Expense)USD | -8,000,000Source | -87,000,000Source | -124,000,000Source | -45,000,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | 0Source |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD | 5,563,000,000Source | 5,562,000,000Source | 5,575,000,000Source | 3,151,000,000Source |
| Proceeds from Stock Options ExercisedUSD | 17,000,000Source | 42,000,000Source | 25,000,000Source | 50,000,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 1,944,000,000Source | 3,236,000,000Source | 6,848,000,000Source | 19,263,000,000Source |
| Cost of RevenueUSD | 868,000,000Source | 1,464,000,000Source | 4,693,000,000Source | 5,416,000,000Source |
| Gross Profit (Calculated) · Derived | — | — | — | — |
| Operating Income (Loss)USD | -3,074,000,000Source | -3,945,000,000Source | -4,239,000,000Source | 9,420,000,000Source |
| Other Nonoperating Income (Expense)USD | -8,000,000Source | -87,000,000Source | -124,000,000Source | -45,000,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -2,768,000,000Source | -3,607,000,000Source | -3,942,000,000Source | 9,575,000,000Source |
| Income Tax Expense (Benefit)USD | 54,000,000Source | -46,000,000Source | 772,000,000Source | 1,213,000,000Source |
| Net Income (Loss) Attributable to ParentUSD | -2,822,000,000Source | -3,561,000,000Source | -4,714,000,000Source | 8,362,000,000Source |
| Earnings Per Share, BasicUSD per share | -7.26Source | -9.28Source | -12.33Source | 21.26Source |
| Earnings Per Share, DilutedUSD per share | -7.26Source | -9.28Source | -12.33Source | 20.12Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 389,000,000Source | 384,000,000Source | 382,000,000Source | 394,000,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 389,000,000Source | 384,000,000Source | 382,000,000Source | 416,000,000Source |
| Additional Financial Items | ||||
| Costs and ExpensesUSD | 5,018,000,000Source | 7,181,000,000Source | 11,087,000,000Source | 9,843,000,000Source |
| Current Income Tax Expense (Benefit)USD | 44,000,000Source | -45,000,000Source | -129,000,000Source | 1,791,000,000Source |
| Equity Securities, FV-NI, Realized Gain (Loss)USD | -8,000,000Source | -52,000,000Source | -35,000,000Source | — |
| General and Administrative ExpenseUSD | 1,018,000,000Source | 1,174,000,000Source | 1,549,000,000Source | 1,132,000,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -2,655,000,000Source | -3,697,000,000Source | -4,056,000,000Source | 9,433,000,000Source |
| Investment Income, InterestUSD | 314,000,000Source | 425,000,000Source | 421,000,000Source | 200,000,000Source |
| Research and Development ExpenseUSD | 3,132,000,000Source | 4,543,000,000Source | 4,845,000,000Source | 3,295,000,000Source |